Barbara Langer
- Epidemiology top 10%
- Hepatology top 2%
- Molecular Biology
- Infectious Diseases
- Immunology
- Topics
- Hepatitis B Virus Studies (6 papers)Hepatitis C virus research (6 papers)Hepatitis Viruses Studies and Epidemiology (4 papers)
- Cited by
- HepatologyEpidemiologyVirology
- Partner nations
- GermanyUnited KingdomUnited States
In The Last Decade
Barbara Langer
17 papers receiving 551 citations
Peers
Comparison fields: 5 of 56
- Epidemiology 461
- Hepatology 457
- Molecular Biology 42
- Infectious Diseases 36
- Immunology 36
Countries citing papers authored by Barbara Langer
This map shows the geographic impact of Barbara Langer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Langer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Langer more than expected).
Fields of papers citing papers by Barbara Langer
This network shows the impact of papers produced by Barbara Langer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Langer. The network helps show where Barbara Langer may publish in the future.
Co-authorship network of co-authors of Barbara Langer
This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Langer. A scholar is included among the top collaborators of Barbara Langer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Langer. Barbara Langer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 6 | |
| 3 | 9 | |
| 4 | 14 | |
| 5 | 24 | |
| 6 | 39 | |
| 7 | 15 | |
| 8 | 27 | |
| 9 | 31 | |
| 10 | 346 | |
| 11 | 37 | |
| 12 | 3 | |
| 13 | 4 | |
| 14 | Adjuvant immunostimulation in malignant melanoma with oral Bacille Calmette-Guérin. | 4 |
| 15 | 3 | |
| 16 | Oral bacille Calmette Guérin immunostimulation in malignant melanoma. | 6 |
| 17 | Use of oral and intraperitoneal BCG in the treatment of malignant melanoma and adenocarcinoma. | 3 |
About Barbara Langer
Barbara Langer is a scholar working on Hepatology, Epidemiology and Biotechnology, having authored 17 papers that have together received 572 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (6 papers), Hepatitis C virus research (6 papers) and Hepatitis Viruses Studies and Epidemiology (4 papers). The work is most often cited by research in Hepatology (457 citations), Epidemiology (461 citations) and Virology (13 citations). Barbara Langer has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include Gert Frösner, Anita Zeller, B. Wiebecke, H. Meisner, John Hess, Manfred Vogt, A. Sendl, Thomas Lang, Albrecht von Brunn and Theoni Petropoulou. Their work appears in journals such as New England Journal of Medicine, Journal of Neurochemistry and Vaccine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.